Menu Search
Equities

BioLife Solutions Inc

BJX1:BER

BioLife Solutions Inc

Actions
Health CareMedical Equipment and Services
  • Price (EUR)24.40
  • Today's Change0.20 / 0.83%
  • Shares traded520.00
  • 1 Year change+98.37%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 14:55 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year BioLife Solutions Inc has grown net income from a loss of -139.81m to a smaller loss of -66.43m despite falling revenues.
Gross margin46.15%
Net profit margin-22.33%
Operating margin-18.30%
Return on assets-6.67%
Return on equity-8.04%
Return on investment-7.37%
More ▼

Cash flow in USDView more

In 2023, BioLife Solutions Inc increased its cash reserves by 81.99%, or 15.97m. Cash Flow from Investing totalled 17.84m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 12.50m for operations while cash generated from financing totalled 10.59m.
Cash flow per share-0.3741
Price/Cash flow per share--
Book value per share7.04
Tangible book value per share1.78
More ▼

Balance sheet in USDView more

BioLife Solutions Inc has a Debt to Total Capital ratio of 6.14%, a lower figure than the previous year's 6.68%.
Current ratio2.78
Quick ratio1.78
Total debt/total equity0.0654
Total debt/total capital0.0614
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.